MBRX Moleculin Biotech, Inc.
Fundamentals / CIK 0001659617 / USDMoleculin Biotech, Inc. reported $0 in revenue and a net loss of $11.42M for the trailing twelve months ended September 30, 2026.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open MBRX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue TTM$0 Sep 30, 2026
-
Operating Income TTM-$29.58M Operating profit
-
Net Income TTM-$11.42M GAAP bottom line
-
Diluted EPS TTM-- Split-adjusted
-
Free Cash Flow TTM-$22.73M Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$7.29M Total debt: $257K
Annual revenue and net income
10 fiscal years (2016 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Research & Development | $15.89M | $17.73M | $19.49M | $18.97M | $14.42M | $12.76M | $11.01M | $9.73M | $4.54M | $1.50M |
| Total Operating Expenses | $25.10M | $26.64M | $29.63M | $30.64M | $22.97M | $19.74M | $17.52M | $15.03M | $8.65M | $3.88M |
| Operating Income | -$25.10M | -$26.64M | -$29.63M | -$30.64M | -$22.97M | -$19.74M | -$17.52M | -$15.03M | -$8.65M | -$3.88M |
| EBITDA | -$25.01M | -$26.52M | -$29.50M | -$30.51M | -$22.80M | -$19.54M | -$17.32M | -$14.96M | -$8.63M | -$3.88M |
| Interest Expense | -- | -- | -- | -- | -- | -- | -- | -- | $0 | $43K |
| Income Before Tax | -$33.56M | -$26.05M | -- | -- | -- | -$17.36M | -$13.43M | -- | -- | -- |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | -$229K | $0 | $0 | $0 |
| Net Income | -$33.56M | -$26.05M | -$29.77M | -$29.02M | -$15.89M | -$17.36M | -$13.21M | -$11.88M | -$9.80M | -$3.93M |
| Basic EPS | -$355,250.00 | -$2,364,250.00 | -$188,375.00 | -$190,250.00 | -$110,625.00 | -$330,000.00 | -$365,625.00 | -$86,250.00 | -$99,375.00 | -$75,000.00 |
| Diluted EPS | -- | -- | -- | -- | -$110,625.00 | -$330,000.00 | -$365,625.00 | -$86,250.00 | -$99,375.00 | -$75,000.00 |
| Basic Shares Outstanding | 95 | 11 | 158 | 153 | 143 | 53 | 36 | 138 | 99 | 52 |
| Diluted Shares Outstanding | -- | -- | -- | -- | 143 | 53 | 36 | 138 | 99 | 52 |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Research & Development | $4.49M | $5.45M | $5.38M | $5.12M | $3.74M | $3.60M | $3.44M | $4.46M |
| Total Operating Expenses | $6.61M | $7.56M | $7.87M | $7.53M | $5.91M | $5.72M | $5.94M | $6.64M |
| Operating Income | -$6.61M | -$7.56M | -$7.87M | -$7.53M | -$5.91M | -$5.72M | -$5.94M | -$6.64M |
| EBITDA | -$6.60M | -$7.55M | -$7.87M | -$7.52M | -$5.88M | -$5.69M | -$5.91M | -$6.61M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$6.49M | -$7.63M | -$12.85M | $15.55M | -$25.40M | -$17.81M | -$5.90M | -$6.58M |
| Basic EPS | -$9.59 | -$700.00 | -$1,770.00 | -- | -$340.43 | -$14,340.00 | -$7,900.00 | -- |
| Basic Shares Outstanding | 757.9K | 11.4K | 8.2K | -- | 74.6K | 1.2K | 748 | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $8.88M | $4.28M | $23.55M | $43.15M | $70.90M | $15.17M | $10.73M | $7.13M | $7.71M | $5.01M |
| Cash & Short-Term Investments | $8.88M | $4.28M | $23.55M | $43.15M | $70.90M | $15.17M | $10.73M | $7.13M | $7.71M | $5.01M |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | -- | $1.0K | $56K | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- | -- | $529K | -- | -- | -- |
| Total Current Assets | $9.69M | $5.19M | $26.27M | $45.60M | $72.50M | $17.20M | $13.48M | $7.97M | $8.30M | $5.22M |
| Property, Plant & Equipment, Net | $78K | $159K | $272K | $275K | $338K | $483K | $316K | $463K | $33K | $23K |
| Other Non-Current Assets | $900K | $0 | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Non-Current Assets | $12.44M | $11.73M | $11.94M | $11.83M | $11.59M | $11.83M | $11.75M | $11.61M | $11.18M | $11.17M |
| Total Assets | $22.13M | $16.93M | $38.22M | $57.42M | $84.09M | $29.03M | $25.23M | $19.59M | $19.48M | $16.39M |
| Accounts Payable | $3.51M | $2.03M | $2.50M | $2.10M | $1.36M | $1.13M | $2.15M | $1.25M | $810K | $399K |
| Total Current Liabilities | $6.85M | $5.36M | $6.82M | $4.82M | $3.62M | $2.92M | $3.57M | $3.88M | $2.21M | $1.34M |
| Total Non-Current Liabilities | $266K | $358K | $5.33M | $412K | $1.48M | $8.35M | $6.09M | $1.44M | $150K | $88K |
| Total Liabilities | $7.12M | $5.72M | $12.14M | $5.23M | $5.10M | $11.27M | $9.66M | $5.31M | $2.37M | $1.43M |
| Total Debt (incl. Leases) | $359K | $478K | $574K | $451K | $159K | $277K | $379K | -- | -- | -- |
| Common Stock | $0 | $0 | $33K | $29K | $29K | $69K | $46K | $29K | $21K | $12K |
| Retained Earnings | -$206.0M | -$172.4M | -$131.6M | -$101.8M | -$72.81M | -$56.92M | -$39.56M | -$26.36M | -$14.48M | -$4.67M |
| Accumulated Other Comp. Income | $10K | -$41K | -- | -- | -- | -- | -- | -- | $0 | -- |
| Total Stockholders' Equity | $15.01M | $11.21M | $30.93M | $52.19M | $78.99M | $17.76M | $15.57M | $14.27M | $17.12M | $14.96M |
| Total Equity | $15.01M | $11.21M | $30.93M | $52.19M | $78.99M | $17.76M | $15.57M | $14.27M | $17.12M | $14.96M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $7.29M | $7.26M | $10.32M | $8.88M | $6.70M | $7.56M | $7.72M | $4.28M |
| Cash & Short-Term Investments | $7.29M | $7.26M | $10.32M | $8.88M | $6.70M | $7.56M | $7.72M | $4.28M |
| Total Current Assets | $8.41M | $8.72M | $10.96M | $9.69M | $7.88M | $9.08M | $9.34M | $5.19M |
| Property, Plant & Equipment, Net | $54K | $62K | $70K | $78K | $77K | $99K | $127K | $159K |
| Other Non-Current Assets | $900K | $900K | $900K | $900K | $900K | $900K | -- | $0 |
| Total Non-Current Assets | $12.32M | $12.36M | $12.40M | $12.44M | $12.47M | $12.52M | $11.67M | $11.73M |
| Total Assets | $20.74M | $21.09M | $23.36M | $22.13M | $20.35M | $21.59M | $21.01M | $16.93M |
| Accounts Payable | $3.69M | $4.34M | $4.57M | $3.51M | $2.12M | $3.72M | $2.71M | $2.03M |
| Total Current Liabilities | $6.13M | $9.31M | $7.96M | $6.85M | $5.68M | $7.91M | $6.90M | $5.36M |
| Total Non-Current Liabilities | $112K | $187K | $218K | $266K | $41.59M | $17.27M | $326K | $358K |
| Total Liabilities | $6.25M | $9.50M | $8.18M | $7.12M | $47.27M | $25.18M | $7.22M | $5.72M |
| Total Debt (incl. Leases) | $257K | $292K | $326K | $359K | $390K | $420K | $450K | $478K |
| Common Stock | $1.0K | $7.0K | $5.0K | $0 | $49K | $30K | $14K | $0 |
| Retained Earnings | -$233.0M | -$226.5M | -$218.8M | -$206.0M | -$221.6M | -$196.2M | -$178.3M | -$172.4M |
| Accumulated Other Comp. Income | -$93K | -$64K | -$52K | $10K | -- | -- | -- | -$41K |
| Total Stockholders' Equity | $14.49M | $11.59M | $15.18M | $15.01M | -$26.92M | -$3.58M | $13.79M | $11.21M |
| Total Equity | $14.49M | $11.59M | $15.18M | $15.01M | -$26.92M | -$3.58M | $13.79M | $11.21M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$33.56M | -$26.05M | -$29.77M | -$29.02M | -$15.89M | -$17.36M | -$13.21M | -$11.88M | -$9.80M | -$3.93M |
| Depreciation & Amortization | $90K | $126K | $127K | $130K | $164K | $200K | $199K | $68K | $18K | $6.0K |
| Stock-Based Compensation | $1.66M | $1.73M | $1.98M | $2.27M | $2.37M | $1.68M | $1.54M | $1.14M | $707K | $324K |
| Change in Payables | $1.33M | -$468K | $403K | $731K | $235K | -$1.02M | $907K | $436K | $411K | -$41K |
| Operating Cash Flow | -$22.73M | -$23.86M | -$23.59M | -$27.64M | -$18.95M | -$17.77M | -$17.20M | -$12.20M | -$7.32M | -$3.77M |
| Capital Expenditure | $0 | -$13K | -$124K | -$67K | -$19K | -$376K | -$52K | -$417K | -$28K | -$21K |
| Free Cash Flow | -$22.73M | -$23.88M | -$23.71M | -$27.71M | -$18.97M | -$18.15M | -$17.25M | -$12.62M | -$7.35M | -$3.79M |
| Acquisitions, Net | -- | -- | -- | -- | -- | -- | -- | -- | $0 | -$100K |
| Investing Cash Flow | $0 | -$13K | -$124K | -$67K | -$19K | -$374K | -$51K | -$417K | -$28K | -$121K |
| Common Stock Issued | -- | -- | -- | $0 | $74.68M | $22.56M | $19.29M | -- | -- | -- |
| Financing Cash Flow | $27.28M | $4.63M | $4.14M | -$23K | $74.72M | $22.55M | $20.85M | $12.04M | $10.06M | $8.87M |
| Net Change in Cash | $4.60M | -$19.27M | -$19.59M | -$27.76M | $55.73M | $4.44M | $3.60M | -$580K | $2.71M | $4.98M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$6.49M | -$7.63M | -$12.85M | $15.55M | -$25.40M | -$17.81M | -$5.90M | -$6.58M |
| Depreciation & Amortization | $8.0K | $8.0K | $8.0K | $9.0K | $21K | $29K | $31K | $31K |
| Stock-Based Compensation | $393K | $436K | $380K | $459K | $303K | $417K | $485K | $427K |
| Change in Payables | -$650K | -$238K | $1.07M | $1.29M | -$1.48M | $850K | $676K | -$520K |
| Operating Cash Flow | -$8.97M | -$6.66M | -$6.11M | -$5.37M | -$7.22M | -$5.58M | -$4.56M | -$5.08M |
| Capital Expenditure | -- | -- | -- | $0 | $0 | $0 | $0 | $0 |
| Free Cash Flow | -- | -- | -- | -$5.37M | -$7.22M | -$5.58M | -$4.56M | -$5.08M |
| Investing Cash Flow | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $9.03M | $3.61M | $7.61M | $7.49M | $6.38M | $5.42M | $8.00M | $1.0K |
| Net Change in Cash | $25K | -$3.06M | $1.44M | $2.17M | -$854K | -$159K | $3.44M | -$5.13M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -223.6% | -232.4% | -96.3% | -55.6% | -20.1% | -97.7% | -84.8% | -83.2% | -57.3% | -26.2% |
| Return on Assets (ROA) | -151.7% | -153.9% | -77.9% | -50.5% | -18.9% | -59.8% | -52.3% | -60.6% | -50.3% | -23.9% |
| Current Ratio | 1.41x | 0.97x | 3.86x | 9.46x | 20.02x | 5.89x | 3.78x | 2.06x | 3.75x | 3.88x |
| Quick Ratio | 1.30x | 0.80x | 3.46x | 8.95x | 19.58x | 5.20x | 3.01x | 1.85x | 3.48x | 3.72x |
| Debt to Equity | 0.02x | 0.04x | 0.02x | 0.01x | 0.00x | 0.02x | 0.02x | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -78.8% | -261.7% | -266.8% | -223.6% | -- | -- | -185.1% | -232.4% |
| Return on Assets (ROA) | -55.1% | -143.8% | -173.4% | -151.7% | -273.7% | -172.8% | -121.5% | -153.9% |
| Current Ratio | 1.37x | 0.94x | 1.38x | 1.41x | 1.39x | 1.15x | 1.35x | 0.97x |
| Quick Ratio | 1.19x | 0.78x | 1.30x | 1.30x | 1.18x | 0.96x | 1.12x | 0.80x |
| Debt to Equity | 0.02x | 0.03x | 0.02x | 0.02x | -- | -- | 0.03x | 0.04x |